非致残性缺血性脑血管病生物标记物研究进展

doi:10.3969/j.issn.1673-5765.2017.12.010

摘要/Abstract

摘要：

短暂性脑缺血发作、轻型卒中和症状迅速缓解未遗留残疾的缺血性脑血管事件统称为非致残性缺血性脑血管事件（non-disabling ischemic cerebrovascular events，NICE），具有早期卒中复发风险高的特点，是严重的、需要紧急干预的事件。至今尚无公认的对NICE预后预测价值高的生物标记物。寻找快速准确的NICE预后的生物学标记物成为目前研究的热点，本文将就血栓形成因子、炎症因子、代谢异常、基因学等对NICE预后的预测价值进行阐述。

文章导读： 本文就与非致残性缺血性脑血管事件风险预测可能相关的生物学标记物进行介绍，有助于更好地评估预后风险。

关键词: 非致残性缺血性脑血管事件; 短暂性脑缺血发作; 生物学标记物; 预测; 综述

Abstract:

Transient ischemic attack (TIA), minor ischemic stroke and rapid remission of ischemic cerebrovascular events collectively are defined as non-disabling ischemic cerebrovascular events (NICE), with a high risk of recurrence of early stroke, which need serious and urgent interventions. However, there are no well-known biomarkers with high value in predicting prognosis after NICE. The researches focus on NICE biomarkers to predict outcome rapidly and accurately has become a hotspot. This review is to provide introduction about biomarkers of NICE from aspects of thrombosis factors, inflammatory factors, metabonomics abnormalities and gene, etc.

Key words: Non-disabling ischemic cerebrovascular events; Transient ischemic attack;Biomarker; Prognosis; Review

司盼，裴璐璐，方慧，郭艺楠，许予明，宋波. 非致残性缺血性脑血管病生物标记物研究进展[J]. 中国卒中杂志, 2017, 12(12): 1119-1122.

SI Pan, PEI Lu-Lu,FANG Hui, GUO Yi-Nan, XU Yu-Ming, SONG Bo. Study Progress of Biomarker in Non-disabling Ischemic Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2017, 12(12): 1119-1122.

参考文献

[1] WANG Y，ZHAO X，JIANG Y，et al. Prevalence，

knowledge，and treatment of transient ischemic attacks

in China[J]. Neurology，2015，84（23）：2354-2361.

[2] LIU J，LI M，LIU J. Evaluation of the ESRS and SPI-

Ⅱ scales for short-term prognosis of minor stroke and

transient ischemic attack[J]. Neurol Res，2013，35（6）：

568-572.

[3] VIGEN T，THOMMESSEN B，RØNNING O M，et

al. Stroke risk is low after urgently treated transient

ischemic attack[J]. J Stroke Cerebrovasc Dis，2017.

[Epub ahead of print]

[4] GRAGNANO F，SPERLONGANO S，GOLIA E，et

al. The Role of von Willebrand factor in vascular

inflammation：from pathogenesis to targeted

therapy[J]. Mediators Inflamm，2017（2017）：

5620314. https://doi.org/10.1155/2017/5620314.

[5] GREISENEGGER S，SEGAL H C，BURGESS A I，et

al. Biomarkers and mortality after transient ischemic

attack and minor ischemic stroke：population-based

study[J]. Stroke，2015，46（3）：659-666.

[6] WILLIAMS S R，HSU F C，KEENE K L，et al.

Genetic drivers of von Willebrand factor levels in an

ischemic stroke population and association with risk

for recurrent stroke[J]. Stroke，2017，48（6）：1444-

1450.

[7] MOHAMMED B M，CONTAIFER D JR，

LASTRAPES K K，et al. Coated platelet assay：a

feasible approach to a complicated science[J/OL].

Haemophilia，2016，22（1）：e67-e70. DOI：10.1111/

hae.12845. http://onlinelibrary.wiley.com/wol1/

doi/10.1111/hae.12845/full.

[8] KIRKPATRICK A C，TAFUR A J，VINCENT A S，

et al. Coated-platelets improve prediction of stroke

and transient ischemic attack in asymptomatic

internal carotid artery stenosis[J]. Stroke，2014，45

（10）：2995-3001.

[9] KIRKPATRICK A C，VINCENT A S，DALE G

L，et al. Coated-platelets predict stroke at 30 days

following TIA[J]. Neurology，2017，89（2）：125-128.

[10] LIN J，ZHENG H，CUCCHIARA B L，et al.

Association of Lp-PLA2-A and early recurrence

of vascular events after TIA and minor stroke[J].

Neurology，2015，85（18）：1585-1591.

[11] DI CASTELNUOVO A，AGNOLI C，DE CURTIS A，

et al. Elevated levels of D-dimers increase the risk of

ischaemic and haemorrhagic stroke. Findings from

the EPICOR Study[J]. Thromb Haemost，2014，112

（5）：941-946.

[12] LI J，ZHAO X，MENG X，et al. High-sensitive

C-reactive protein predicts recurrent stroke and poor

functional outcome：subanalysis of the clopidogrel

in high-risk patients with acute nondisabling

cerebrovascular events trial[J]. Stroke，2016，47（8）：

2025-2030.

[13] YANG Y，LIU H，ZHANG H，et al. ST2/IL-33-

dependent microglial response limits acute ischemic

brain injury[J]. J Neurosci，2017，37（18）：4692-4704.

[14] QIAN L，YUANSHAO L，WENSI H，et al. Serum

IL-33 is a novel diagnostic and prognostic biomarker

in acute ischemic stroke[J]. Aging Dis，2016，7（5）：

614-622.

[15] BONAVENTURA A，LIBERALE L，VECCHIÉ

A，et al. Update on inflammatory biomarkers and

treatments in ischemic stroke[J]. Int J Mol Sci，2016，

17（12）：1967. DOI:10.3390/ijms17121967. http://www.mdpi.com/1422-0067/17/12/1967.

[16] JIA Q，ZHAO X，WANG C，et al. Diabetes and

poor outcomes within 6 months after acute ischemic

stroke：the China National Stroke Registry[J]. Stroke，

2011，42（10）：2758-2762.

[17] LI J，WANG Y，WANG D，et al. Glycated albumin

predicts the effect of dual and single antiplatelet

therapy on recurrent stroke[J]. Neurology，2015，84

（13）：1330-1336.

[18] PAN Y，JING J，LI H，et al. Abnormal glucose

regulation increases stroke risk in minor ischemic

stroke or TIA[J]. Neurology，2016，87（15）：1551-

1556.

[19] ZHOU Y，PAN Y，WU Y，et al. Effect of estimated

glomerular filtration rate decline on the efficacy and

safety of clopidogrel with aspirin in minor stroke

or transient ischemic attack：CHANCE Substudy

（clopidogrel in high-risk patients with acute

nondisabling cerebrovascular events）[J]. Stroke，

2016，47（11）：2791-2796.

[20] CANFRÁN-DUQUE A，LIN C S，GOEDEKE

L，et al. Micro-RNAs and high-density lipoprotein

metabolism[J]. Arterioscler Thromb Vasc Biol，2016，

36（6）：1076-1084.

[21] WU J，FAN C L，MA L J，et al. Distinctive

expression signatures of serum microRNAs in

ischaemic stroke and transient ischaemic attack

patients[J]. Thromb Haemost，2017，117（5）：992-

1001.

[22] MIRZAEI H，MOMENI F，SAADATPOUR L，et al.

MicroRNA：relevance to stroke diagnosis，prognosis，

and therapy[J]. J Cell Physiol，2017，233（2）：856-

865.

[23] WANG Y，ZHAO X，LIN J，et al. Association

between CYP2C19 loss-of-function allele status

and efficacy of clopidogrel for risk reduction among

patients with minor stroke or transient ischemic

attack[J]. JAMA，2016，316（1）：70-78.

[24] LI J，WANG Y，LIN J，et al. Soluble CD40L is a

useful marker to predict future strokes in patients

with minor stroke and transient ischemic attack[J].

Stroke，2015，46（7）：1990-1992.

[25] TOBIN M K，BONDS J A，MINSHALL R D，et

al. Neurogenesis and inflammation after ischemic

stroke：what is known and where we go from here[J].

J Cereb Blo